Natco Pharma Limited has informed the Exchange about Action(s) initiated or orders passed

NATCOPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-3.0%1-day move

₹1206.80

prior close

₹1206.80

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.1-0.3+0.0+0.7-3.0-6.6-4.1-2.6-3.0-1.5-27.9-29.8-19.7—

Up moveDown movePending

AI summary

Natco Pharma has received a demand notice dated 12th May, 2026 from the National Pharmaceutical Pricing Authority (NPPA). The notice directs the company to deposit ₹4,92,25,923, which includes overcharged amount, penalty, and interest. The allegation is that the company overcharged for 2 drugs during the period April 2023 to November 2023, in violation of the Drugs Price Control Order, 2013. The company has stated that this demand has no material impact on its financial, operational, or other activities. The company has disclosed this under SEBI's Regulation 30 listing obligations.

Likely market impact

While the demand is for nearly ₹5 crore, the company claims no material financial impact. However, this could invite further regulatory scrutiny from NPPA and may attract negative market sentiment given the penalty and interest component.